INTENDED USE
The test kit utilize purified Chlamydia Trachomatis Antibody antigen, based on GIFA principle and use indirect method to detect Urea Plasma Urealyticum antibody in human serum.
TEST PROCEDURE
1. Remove the test kit and put it at room temperature (for about 20-30mins) before testing.
2. Add 1 drop of Wash Buffer into the hole and allow the liquid soak the membrane completely.
3. Add 150ï½?l of the serum specimen into the hole and allow it to sufficient absorption.
4. Add 3 drops of Colloidal Conjugate into the hole and allow it to sufficient absorption.
5. Add 3 drops of Wash Buffer into the hole and allow it to sufficient absorption. Read the results within 3 minutes.
STORAGE
The kit can be stored at room temperature (2-30°C). The test kit is stable through the expiration date (18 months) marked on the foil pouch. DO NOT FREEZE. Do not store the test kit in direct sunlight.
Supplier: Rapid detection kit, ribonucleic acid detection reagent, medical syringes, medical mask, medical ventilator, medical glove, medical isolation gown, surgical gown level 3+4, protective gown (overall ), oximeter, other medical products
Our COVID-19 rapid test kit can be used effectively on many levels for proper screening and strategic preparedness toward the pandemic. The test kit requires no sophisticated equipment nor laboratory settings. Our SARS-COV-2 Antibody Rapid Test Kit can be applied for screening of COVID-19 disease on the following: General practitioners and external clinics level to detect previous SARS-COV-2 viral infections on both symptomatic and asymptomatic patients. Determination of the immunity level of front-line healthcare workers, which can help in the development of pandemic preparedness strategies at national levels. Epidemiological COVID-19 surveys at national and district levels for research purposes. Airport screening for arriving /departing passengers to control the pandemic in the aviation industry. Suspected cases exclusion to minimize cost and time spent in the RT-PCR testing procedures. Screening on the national level to facilitate decision making regarding lockdown and curfew easing strategies. Phoenix Bioscience is offering a competitive price for a high-quality kit that is made in Canada and used currently to combat the pandemic in most American cities.
COVID-19 IgG/IgM Rapid Test Kit (Colloidal Gold) The accuracy of the rapid test is 93% for IgM detection and 98% for IgG detection, compared to the RT-PCR Tests done at individual labs in The Netherlands. Pricing clears and depends on volumes naturally. Please ask the exact quote with the volume requested information. CE and FDA EUA approved Made in USA, Germany, Canada
In the past two months, China was infected by the COVID-19( Noval Coronavirus), in order to diagnose the diseases earlier, Encode team work hard and finally develop the COVID-19 IgM/IgG rapid test kit, which clinical positive detection rate is over 90%.
A rapid test for the qualitative detection of antibodies (IgG and IgM) to Dengue virus in whole blood, serum, or plasma. For professional in vitro diagnostic use only. INTENDED USE The Dengue IgG/IgM Rapid Test Device (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to Dengue virus in human whole blood, serum, or plasma as an aid in the diagnosis of primary and secondary Dengue infections. DIRECTIONS FOR USE Allow the test device, specimen, buffer, and/or controls to reach room temperature (1530°C) prior to testing. 1.Bring the pouch to room temperature before opening. Remove the test device from the sealed pouch and use it as soon as possible. 2.Place the test device on a clean and level surface. For Serum or Plasma Specimens: Hold the dropper vertically, draw the specimen up to the Fill Line (approximately 5 μL), and transfer the specimen to the specimen well (S) of the test device, then add 3 drops of buffer (approximately 90 L) and start the timer. See illustration below. Avoid trapping air bubbles in the specimen well (S). For Whole Blood (Venipuncture/Fingerstick) Specimens: To use a dropper: Hold the dropper vertically, draw the specimen 0.5-1 cm above the Fill Line, and transfer 1 drop of whole blood (approximately 10 µL) to the specimen well (S) of the test device, then add 3 drops of buffer (approximately 90 uL) and start the timer. See illustration below. To use a micropipette: Pipet and dispense 10 µL of whole blood to the specimen well (S) of the test device, then add 3 drops of buffer (approximately 90 µL) and start the timer. See illustration below. 3.Wait for the colored line(s) to appear. Read results at 10 minutes. Do not interpret the result after 20 minutes.
Till now we already exported 20 million tests and we can promise you very high quality. 25 tests/box, CE Mark and ISO, Clinical report, Certificate of analysis (COA) available Clinical specify >98.89% Accuracy: 93.41% Specimen: whole blood/serum, 10 minutes to get results
Rapid 2019-nCoV IgG/IgM Combo Test Card is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019-nCoV, SARS-CoV-2) in human serum, plasma, or whole blood. Rapid 2019-nCoV IgG/IgM Combo Test Card is a supplement detection for COVID-19 suspected infected patients besides nucleic acid test, which could greatly raise the accuracy of the detection for COVID-19. 25 tests/box, CE Mark and ISO, Clinical report, Certificate of analysis (COA) Clinical specify >98.89% Accuracy: 93.41% Specimen: whole blood/serum, 10 minutes to get results
Hi need covid-19 igg/igm rapid tear cassette? Promise you very high quality, and till now we already export more than 20 million tests and our Europe client said our product this way: you are the brain the world